Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZD1839 (Iressa) in Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
NCT00054691Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2004
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in squamous cell carcinoma of the skin (SCC), sponsored by University of Texas MD Anderson Cancer Center. Started May 2004; status: completed.
02
Drugs
03
Conditions
squamous cell carcinoma of the skin (SCC)
Beyond the preview
Go deeper on NCT00054691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054691.